Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Adults with obsessive compulsive disorder face higher risk of ischemic stroke

Adults who have obsessive-compulsive disorder (OCD) were more than three times as likely to have an ischemic stroke later in life compared to adults who do not have OCD, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

27 May 2021

Oligo DNA improves differentiation of skeletal muscles exacerbated by diabetes

Skeletal muscle is the largest organ in the body that accounts for 30 to 40% of body weight and is responsible for multiple functions such as energy metabolism and heat production.

27 May 2021

Researchers discover new brain circuit that may help fight obesity

Like a good story, feeding has a beginning, a middle and an end. It begins with appetite prompting the search for food, continues with eating the food and it ends when satiation hits and the consumption of food is stopped.

27 May 2021

Pandemic leads doctors to rethink unnecessary treatment

Covid-19 is opening the door for researchers to address a problem that has vexed the medical community for decades: the overtreatment and unnecessary treatment of patients.

25 May 2021

New immunotherapy shows promising results in subgroup of people with type 1 diabetes

A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin.

24 May 2021

Gestational diabetes during pregnancy can increase risk of type-1 and type-2 diabetes

A 23 year study being presented at the 23rd European Congress of Endocrinology (e-ECE 2021), on Monday 24 May 2021 at 14:40 CET, has found that women who experience gestational diabetes (GDM) when they are pregnant, are more prone to developing type-1 and type-2 diabetes later in life.

24 May 2021

Regular consumption of milk is not linked to increased cholesterol, shows study

Regular consumption of milk is not associated with increased levels of cholesterol, according to new research.

23 May 2021

Study could lead to new antibiotics to fight bacterial infections

One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.

21 May 2021

Asthma patients can benefit from type 2 diabetes medication

Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

21 May 2021

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

A new multi-institution study led by a team of researchers at the David Geffen School of Medicine demonstrated that blocking a protein called ABCB10 in liver cells protects against high blood sugar and fatty liver disease in obese mice.

20 May 2021

Study confirms that human endocrine system is strongly involved in SARS-Cov-2 infection

The endocrine system is strongly involved in SARS-Cov-2 infection - so much so that evidence of an "endocrine phenotype" of COVID-19 has emerged, according to a statement by the European Society of Endocrinology (ESE) published in the journal Endocrine in April 2021.

20 May 2021

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

Researchers have reported the first case of COVID-19 triggering a rare occurrence of potentially severe blood clots forming in the arms.

19 May 2021

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Analysing the forces at work behind the obstructions that cause heart attacks is crucial for identifying patients at risk of these events, says a study published today in eLife.

19 May 2021

Researchers report promising biotherapeutics for obesity and related medical complications

The research teams at the University of Hong Kong led by Professor Xuechen LI from the Research Division for Chemistry and Department of Chemistry, and Professor Yu WANG from the Department of Pharmacology and Pharmacy, reported a synthetic biotherapeutics with promising anti-tumor, insulin sensitising and hepatoprotective activities in the Journal of the American Chemical Society.

18 May 2021

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

We are truly never alone, not even within our own bodies. Human beings play host to trillions of bacteria, fungi, viruses, and other microorganisms that make up the human microbiome.

18 May 2021

A potential treatment to prevent obesity-related liver damage

One of the especially dangerous health risks of being extremely overweight occurs when an obese person begins to accumulate fat in their liver.

18 May 2021

Study highlights the need for more personalized approach to measuring BMI

The results of an extensive new study funded by the National Institute for Health Research (NIHR), Ethnic-specific BMI cut-off points for obesity based on type 2 diabetes mellitus risk: a cohort study of 1.5 million people in England, presented at this year’s European Congress on Obesity (ECO) and published simultaneously in the leading journal, The Lancet Diabetes & Endocrinology reveal that inaccurate and outdated interpretations of the standard Body Mass Index (BMI) values for patients from BAME backgrounds in England could potentially be putting their health at risk.

17 May 2021

What can ancient feces tell us about the evolution of the human gut microbiome?

Researchers at the Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center in Boston, Massachusetts, analyzed microbial DNA found in indigenous human paleofeces (desiccated excrement) from dry caves in northern Mexico and Utah. They found that the ancient human gut microbiome is similar to those of modern-day people from non-industrialized populations.

14 May 2021

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.

From AstraZeneca 14 May 2021

Ancient people had far different microorganisms in their guts than modern humans

Only an anthropologist would treasure millennia-old human feces found in dry caves. Just ask Dr. Meradeth Snow, a University of Montana researcher and co-chair of UM's Department of Anthropology.

13 May 2021

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Adults with obsessive compulsive disorder face higher risk of ischemic stroke

Oligo DNA improves differentiation of skeletal muscles exacerbated by diabetes

Researchers discover new brain circuit that may help fight obesity

Pandemic leads doctors to rethink unnecessary treatment

New immunotherapy shows promising results in subgroup of people with type 1 diabetes

Gestational diabetes during pregnancy can increase risk of type-1 and type-2 diabetes

Regular consumption of milk is not linked to increased cholesterol, shows study

Study could lead to new antibiotics to fight bacterial infections

Asthma patients can benefit from type 2 diabetes medication

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

Study confirms that human endocrine system is strongly involved in SARS-Cov-2 infection

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Researchers report promising biotherapeutics for obesity and related medical complications

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

A potential treatment to prevent obesity-related liver damage

Study highlights the need for more personalized approach to measuring BMI

What can ancient feces tell us about the evolution of the human gut microbiome?

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Ancient people had far different microorganisms in their guts than modern humans

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in